Mr. Holden speaks to issues including the company’s top volume procedures, trends driving future growth, impact of removal of the copay for screening rates for colonoscopies and the company’s approach to acquisitions.
Read the Q&A from The Tennessean with Christopher Holden.
Read more about AmSurg:
– AmSurg Reports 11% Increase in Revenues, 2% Increase in Average Revenue Per Procedure
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.